Vericel's Q4 Swoon: The Fainting Spell Is Temporary [Seeking Alpha]
Vericel Corporation (VCEL)
Last vericel corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vcel.com/investor-relations
Company Research
Source: Seeking Alpha
Vericel's Q4 Swoon: The Fainting Spell Is Temporary Summary Vericel's 4th quarter earnings release resulted in a surprising wide-ranging down day, despite beats on income and revenue. The earnings day price swoon was a result of disappointing guidance and a clouding of the Epicel picture. But, should we be worried? In a word: no. Management's mention of ReCell complicates the Epicel picture; is it a competitor, an acquisition target, or a non-factor? (Or, perhaps all three?). Technically, despite the earnings day hiccup, Vericel continues stair-stepping upward. We knew it had to end sometime. After four outstanding earnings day moves, including three gap-ups and third quarter 2018's spectacular +44% price explosion, on February 26, 2019, Vericel ( VCEL It is my assertion that the wide-ranging down reaction to the 4th quarter earnings release was the product of Vericel's "low ball" guidance figures for 2019, combined with the mention of what seemed at first glance to be a competitor to
Show less
Read more
Impact Snapshot
Event Time:
VCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCEL alerts
High impacting Vericel Corporation news events
Weekly update
A roundup of the hottest topics
VCEL
News
- Vericel Corporation (NASDAQ:VCEL) On The Verge Of Breaking Even [Yahoo! Finance]Yahoo! Finance
- Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb [Yahoo! Finance]Yahoo! Finance
- Vericel Co. (NASDAQ: VCEL) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $54.00 price target on the stock.MarketBeat
- Treatment Options to Help Overcome Knee Pain for Sports Enthusiasts [Yahoo! Finance]Yahoo! Finance
- US$52.07 - That's What Analysts Think Vericel Corporation (NASDAQ:VCEL) Is Worth After These Results [Yahoo! Finance]Yahoo! Finance
VCEL
Earnings
- 2/29/24 - Beat
VCEL
Analyst Actions
- 1/30/24 - TheStreet
VCEL
Sec Filings
- 4/18/24 - Form 144
- 4/17/24 - Form 144
- 4/11/24 - Form 4
- VCEL's page on the SEC website